These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 12622758

  • 1. 6-thioguanine--efficacy and safety in chronic active Crohn's disease.
    Herrlinger KR, Kreisel W, Schwab M, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Deibert P, Fellermann K, Greinwald R, Stange EF.
    Aliment Pharmacol Ther; 2003 Feb 15; 17(4):503-8. PubMed ID: 12622758
    [Abstract] [Full Text] [Related]

  • 2. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N, Tsoulis DJ, MacDonald JK.
    Cochrane Database Syst Rev; 2013 Apr 30; (4):CD000545. PubMed ID: 23633304
    [Abstract] [Full Text] [Related]

  • 3. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW, Tsoulis DJ, Macdonald JK, Feagan BG.
    Cochrane Database Syst Rev; 2012 Dec 12; 12():CD003459. PubMed ID: 23235598
    [Abstract] [Full Text] [Related]

  • 4. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E, Macdonald JK, Sutherland LR.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD000545. PubMed ID: 19821270
    [Abstract] [Full Text] [Related]

  • 5. Remission maintenance by tioguanine in chronic active Crohn's disease.
    Herrlinger KR, Deibert P, Schwab M, Kreisel W, Fischer C, Fellermann K, Stange EF.
    Aliment Pharmacol Ther; 2003 Jun 15; 17(12):1459-64. PubMed ID: 12823147
    [Abstract] [Full Text] [Related]

  • 6. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E, Macdonald JK, Sutherland LR.
    Cochrane Database Syst Rev; 2010 Jun 16; (6):CD000545. PubMed ID: 20556747
    [Abstract] [Full Text] [Related]

  • 7. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.
    Bonaz B, Boitard J, Marteau P, Lémann M, Coffin B, Flourié B, Belaiche J, Cadiot G, Metman EH, Cortot A, Colombel JF, Getaid.
    Aliment Pharmacol Ther; 2003 Aug 15; 18(4):401-8. PubMed ID: 12940925
    [Abstract] [Full Text] [Related]

  • 8. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.
    Sandborn WJ, Tremaine WJ, Wolf DC, Targan SR, Sninsky CA, Sutherland LR, Hanauer SB, McDonald JW, Feagan BG, Fedorak RN, Isaacs KL, Pike MG, Mays DC, Lipsky JJ, Gordon S, Kleoudis CS, Murdock RH.
    Gastroenterology; 1999 Sep 15; 117(3):527-35. PubMed ID: 10464128
    [Abstract] [Full Text] [Related]

  • 9. 6-Thioguanine therapy in Crohn's disease--observational data in Swedish patients.
    Almer SH, Hjortswang H, Hindorf U.
    Dig Liver Dis; 2009 Mar 15; 41(3):194-200. PubMed ID: 18799369
    [Abstract] [Full Text] [Related]

  • 10. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 11. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR, Pierik M, Seinen ML, van Bodegraven AA, Gilissen LP, Bus P, Bakker JA, Masclee AA, Neef C, Engels LG, Hooymans PM.
    J Crohns Colitis; 2014 Feb 01; 8(2):120-8. PubMed ID: 23932783
    [Abstract] [Full Text] [Related]

  • 12. Azathioprine: state of the art in inflammatory bowel disease.
    Sandborn WJ.
    Scand J Gastroenterol Suppl; 1998 Feb 01; 225():92-9. PubMed ID: 9515759
    [Abstract] [Full Text] [Related]

  • 13. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D, Macdonald JK, Chande N.
    Cochrane Database Syst Rev; 2014 Feb 21; (2):CD010410. PubMed ID: 24558033
    [Abstract] [Full Text] [Related]

  • 14. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease.
    Cuffari C, Hunt S, Bayless T.
    Gut; 2001 May 21; 48(5):642-6. PubMed ID: 11302961
    [Abstract] [Full Text] [Related]

  • 15. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study.
    Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G.
    Dig Liver Dis; 2003 Sep 21; 35(9):619-27. PubMed ID: 14563183
    [Abstract] [Full Text] [Related]

  • 16. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Prefontaine E, Sutherland LR, Macdonald JK, Cepoiu M.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD000067. PubMed ID: 19160175
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporine for induction of remission in Crohn's disease.
    McDonald JW, Feagan BG, Jewell D, Brynskov J, Stange EF, Macdonald JK.
    Cochrane Database Syst Rev; 2005 Apr 18; (2):CD000297. PubMed ID: 15846602
    [Abstract] [Full Text] [Related]

  • 18. Enhanced bioavailability of azathioprine compared to 6-mercaptopurine therapy in inflammatory bowel disease: correlation with treatment efficacy.
    Cuffari C, Hunt S, Bayless TM.
    Aliment Pharmacol Ther; 2000 Aug 18; 14(8):1009-14. PubMed ID: 10930894
    [Abstract] [Full Text] [Related]

  • 19. An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy.
    Dubinsky MC, Hassard PV, Seidman EG, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA.
    Inflamm Bowel Dis; 2001 Aug 18; 7(3):181-9. PubMed ID: 11515842
    [Abstract] [Full Text] [Related]

  • 20. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment.
    Derijks LJ, de Jong DJ, Gilissen LP, Engels LG, Hooymans PM, Jansen JB, Mulder CJ.
    Eur J Gastroenterol Hepatol; 2003 Jan 18; 15(1):63-7. PubMed ID: 12544696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.